Clinical Trial Update: Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial results comparing three combination chemotherapy regimens in adults with relapsed or refractory acute myeloid leukemia; the study is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 2 | Status: COMPLETED | Results posted: 2015-07-07